The international newspaper for spine specialists
Synaptive Medical has announced US Food and Drug Administration (FDA) registration of its next-generation robotic exoscope, Modus X...
Synaptive Medical has announced US Food and Drug Administration (FDA) registration of its next-generation robotic exoscope, Modus X.
Emad Ibrahim, director of the Male Fertility Research Program at The Miami Project to Cure Paralysis and the clinical andrology lab at the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine (Miami, USA), has been awarded a US$3.25 million grant by the Department of Defense for a four-year study on the use of an oral medication to treat an infertility issue that affects most men with spinal cord injury (SCI)...
Emad Ibrahim, director of the Male Fertility Research Program at The Miami Project to Cure Paralysis and the clinical andrology lab at the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine (Miami, USA), has been awarded a US$3.25 million grant by the Department of De...
Woven Orthopedic Technologies has announced that its Ogmend implant enhancement system has received 510(k) clearance from the US Food and Drug Administration (FDA) for use in spine surgery...
Woven Orthopedic Technologies has announced that its Ogmend implant enhancement system has received 510(k) clearance from the US Food and Drug Administration (FDA) for use in spine surgery.
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS). The devices are intended for the treatment of patients with chronic back pain due to multiple failed back surgery syndrome, intractable low back and leg pain...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS). The devices are intended for the treatment of patients with chronic back pain due to multiple failed back surgery syndrome, intra...
Accelus has announced that the US Food & Drug Administration (FDA) has issued it 510(k) clearance for its Remi robotic navigation system for use with OEC 9900 C-Arm fluoroscopic imaging systems (GE Healthcare)...
Accelus has announced that the US Food & Drug Administration (FDA) has issued it 510(k) clearance for its Remi robotic navigation system for use with OEC 9900 C-Arm fluoroscopic imaging systems (GE Healthcare).
When considering interbody material for transforaminal lumbar interbody fusion (TLIF), both standard solid titanium (ST) and 3D-printed porous titanium (3DPT) cages perform well. However, 3DPT cages are associated with lower rates of subsidence. This is the key findings of a recent retrospective study, the findings of which were published in the Global Spine Journal by Nathaniel Toop (Ohio State University School of Medicine, Columbus, USA) et al...
When considering interbody material for transforaminal lumbar interbody fusion (TLIF), both standard solid titanium (ST) and 3D-printed porous titanium (3DPT cages perform well.
Expanding Innovations recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its X-PAC expandable lateral cage system (X-PAC LLIF)...
Expanding Innovations recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its X-PAC expandable lateral cage system (X-PAC LLIF).
Despite significant data heterogeneity, a new systematic review and meta-analysis has shown that both neurosurgeons and orthopaedic spine surgeons have similar readmission, complication, and reoperation rates regardless of the type of spine surgery performed. The research, which was published in the journal Spine by Jose A. Canseco (Rothman Orthopaedic Institute, Philadelphia, USA) et al, was designed to identify if intraoperative or postoperative differences in outcomes exist between orthopaedic and neurological spine surgeons...
Despite significant data heterogeneity, a new systematic review and meta-analysis has shown that both neurosurgeons and orthopaedic spine surgeons have similar readmission, complication, and reoperation rates regardless of the type of spine surgery performed.
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of Health and Social Care (DHSC)—to help bring innovative new medicines and medical technologies to UK patients more quickly, His Majesty’s (HM) Treasury has announced...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of Health and Social Care (DHSC)—to help bring innovative new medicines and medical technologies to UK patients more quickly, His Majesty’s (HM) T...
Smoking and a higher preoperative disability are both independent risk factors for same-site recurrent disc herniation (sRDH), according to a new study which was published in The Bone and Joint Journal by Jonathan Geere (Spire Norwich Hospital, Norwich, UK) et al...
Smoking and a higher preoperative disability are both independent risk factors for same-site recurrent disc herniation (sRDH), according to a new study which was published in The Bone and Joint Journal by Jonathan Geere (Spire Norwich Hospital, Norwich, UK) et al.
Stratus Medical has announced the first patient enrolled in the COBRA study, a double-blinded, randomised trial, comparing the bipolar treatment with Nimbus RF multitined expandable electrode to conventional radiofrequency ablation for the treatment of sacroiliac joint (SIJ) pain...
Stratus Medical has announced the first patient enrolled in the COBRA study, a double-blinded, randomised trial, comparing the bipolar treatment with Nimbus RF multitined expandable electrode to conventional radiofrequency ablation for the treatment of sacroiliac joint (SIJ) pain.
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs, offsetting device acquisition costs within 27 months, according to a recent analysis published in Neuromodulation: Technology at the Neural Interface...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs, offsetting device acquisition costs within 27 months, according to a recent analysis published in Neuromodulation: Technology...
InVivo Therapeutics has announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold, a bioresorbable scaffold-based device in development for patients with acute spinal cord injury (SCI)...
InVivo Therapeutics has announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold, a bioresorbable scaffold-based device in development for patients with acute spinal cord injur...
NuVasive has, this week, announced the 20-year milestone achievement of its lateral lumbar procedure, extreme lateral interbody fusion (XLIF)...
NuVasive has, this week, announced the 20-year milestone achievement of its lateral lumbar procedure, extreme lateral interbody fusion (XLIF).
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following the completion of a successful limited market release...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following the completion of a successful limited market release. “This is an exciting time in spinal cord stimulation—better waveforms, more conditions we can...
The utilisation and satisfaction of telemedicine has remained high among spine patients, even after the easing of COVID-19 lockdown restrictions. This is according to a new study, published in the journal Spine by Sheeraz Qureshi (Hospital for Special Surgery, New York, USA) et al, which found that almost a third of spine patients still used telemedicine visits post lockdown...
The utilisation and satisfaction of telemedicine has remained high among spine patients, even after the easing of COVID-19 lockdown restrictions.
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR)...
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR). Producers of medical devices will have until 31 December 2027 for higher risk devices and until 31 December 2028 for ...
There is no benefit of adding instrumented fusion to decompression for treating degenerative spondylolisthesis (DS), according to a recent systematic review and meta-analysis, the findings of which were published in the Journal of Neurology, Neurosurgery, and Psychiatry by Radek Kaiser (Charles University, Prague, Czech Republic) et al...
There is no benefit of adding instrumented fusion to decompression for treating degenerative spondylolisthesis (DS), according to a recent systematic review and meta-analysis.
Surgeons failed to achieve their preoperative goal alignment of each sagittal parameter in approximately 25-30% of adult spinal deformity (ASD) patients and goal alignment for all three parameters was only achieved in 37.2% of patients. This is according to a recent study—the findings of which were published in the Global Spine Journal by Justin Smith (University of Virginia, Charlottesville, USA) et al—which also highlighted that those at greatest risk were patients with more severe deformity...
Surgeons failed to achieve their preoperative goal alignment of each sagittal parameter in approximately 25-30% of adult spinal deformity (ASD) patients and goal alignment for all three parameters was only achieved in 37.2% of patients.
Research looking at the Vertebral Bone Quality Score as a predictor of pedicle screw loosening was our most viewed story in February, followed by news of a milestone for Augmedics’ xvision spine system and a study on risk factors of medical malpractice litigation due to laminectomy. Making up the rest of the Top 10 was research on the demand for posterior spinal fusion as well as industry news from the likes of DiscGenics, NuVasive, Globus Medical and icotec...
Research looking at the Vertebral Bone Quality Score as a predictor of pedicle screw loosening was our most viewed story in February, followed by news of a milestone for Augmedics’ xvision spine system and a study on risk factors of medical malpractice litigation due to laminectomy. Making up the ...
Premia Spine has announced the publication of two-year outcomes from the TOPS facet joint replacement system’s clinical trial in the Journal of Neurosurgery Spine, which found that found lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement versus lumbar fusion in all patient-reported outcome measures, a low surgical complication rate, and the ability to maintain motion at the index level while limiting sagittal translation...
Premia Spine has announced the publication of two-year outcomes from the TOPS facet joint replacement system’s clinical trial in the Journal of Neurosurgery Spine, which found that found lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement versus lumb...
Christopher Gilligan, director of Brigham and Women’s Spine Service Line and associate chief medical officer of Brigham and Women’s Hospital (Boston, USA) talks to Spinal News International about restorative neurostimulation and how this technology can help treat those patients who suffer chronic low back pain...
Christopher Gilligan, director of Brigham and Women’s Spine Service Line and associate chief medical officer of Brigham and Women’s Hospital (Boston, USA) talks to Spinal News International about restorative neurostimulation and how this technology can help treat those patients who suffer chroni...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to perform daily activities more easily, as reported in Nature Medicine by researchers from the University of Pittsburgh and Carnegie Mellon University in Pittsburgh, USA...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to perform daily activities more easily, as reported in Nature Medicine by researchers from the University of Pittsburgh and Carnegie M...
Aurora Spine has announced that it has received Institutional Review Board (IRB) approval for its new multicentre study of its DEXA-C cervical interbody system, which is indicated for anterior cervical interbody fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one or two contiguous levels from C2–T1...
Aurora Spine has announced that it has received Institutional Review Board (IRB) approval for its new multicentre study of its DEXA-C cervical interbody system.
Xtant Medical has acquired the Coflex and Cofix product lines from Surgalign for a total consideration of US$17 million...
Xtant Medical has acquired the Coflex and Cofix product lines from Surgalign for a total consideration of US$17 million.
Is the relationship between industry and randomised controlled trials (RCTs) too cosy? Or instead, is it a vital relationship that can help drive improvements and innovation within the field? Maybe it is somewhere in between the two. Spinal News International asks four physicians to give their take on this important question...
Is the relationship between industry partners and randomised controlled trials too cosy? Or instead, is it a vital relationship that can help drive improvements and innovation within the field? Maybe it is somewhere in between the two.
Patients with Ehlers-Danlos syndrome (EDS) are at increased risk of both medical and surgical complications following anterior cervical discectomy and fusion (ACDF). As such, spine surgeons should be cognisant of the increased risks in this patient population and provide appropriate preoperative counselling and enhanced perioperative medical management. This is according to research published in the Global Spine Journal by Xudong Li (University of Virginia, Charlottesville, USA) et al...
Patients with Ehlers-Danlos syndrome (EDS) are at increased risk of both medical and surgical complications following anterior cervical discectomy and fusion (ACDF).
The demand for posterior spinal fusion procedures is expected to increase by more than 80% by 2060. In addition, the demand will be even greater among older patients, who often need more costly care, and so placing an enormous strain on healthcare systems. These are the key projections to come from a study published in Clinical Orthopaedics and Related Research by Vincent Heck (University of Cologne, Cologne, Germany) et al...
The demand for posterior spinal fusion procedures is expected to increase by more than 80% by 2060.
Static flexion, in combination with compression, negatively impacts the intralamellar and interlamellar matrix properties of the annulus fibrosus. This is the key finding of a new study, published in the European Spine Journal by Diane Gregory (Wilfrid Laurier University, Waterloo, Canada) et al...
Static flexion, in combination with compression, negatively impacts the intralamellar and interlamellar matrix properties of the annulus fibrosus.
Centinel Spine has announced the completion of the 500th procedure in the USA with its latest US Food and Drug Administration (FDA)-approved total disc replacement (TDR) system of prodisc cervical solutions, prodisc C Vivo and prodisc C SK. The milestone comes less than two months after Centinel Spine announced the completion of 250 procedures with the system...
Centinel Spine has announced the completion of the 500th procedure in the USA with its latest US Food and Drug Administration (FDA)-approved total disc replacement (TDR) system of prodisc cervical solutions, prodisc C Vivo and prodisc C SK.
Be the first to know and let us send you an email when Spinal News International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Want your business to be the top-listed Media Company?
